Irinotecan Sucrosofate
tetrakis([(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate);[(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfooxy-2,5-bis(sulfooxymethyl)oxolan-2-yl]oxy-3,5-disulfooxy-6-(sulfooxymethyl)oxan-4-yl] hydrogen sulfate
Molecular Identity
Irinotecan Sucrosofate
tetrakis([(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate);[(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfooxy-2,5-bis(sulfooxymethyl)oxolan-2-yl]oxy-3,5-disulfooxy-6-(sulfooxymethyl)oxan-4-yl] hydrogen sulfate
PubChem CID: 76964235
2D Structure
Properties
C144H174N16O59S8
Molecular Formula
3329.50
Molecular Weight
g/mol
3327.8906
Exact Mass
Da
1050
TPSA
May have limited oral absorption
12
H-Bond Donors
67
H-Bond Acceptors
3440
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(14)
Irinotecan SucrosofatePEP-02MM-398OL741S3N8Birinotecan liposomenal-IRINanoliposomal IrinotecanRefChem:923557PEP02Nanoparticle Liposome Formulation of Irinotecan1361317-83-0CHEMBL5314381IRINOTECAN SUCROSOFATE [WHO-DD]SULFATE OF SUCROSE (ESTER) AND OF IRINOTECAN (SALT): SUCROSE OCTAKIS(HYDROGEN SULFATE) SALT WITH (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-9-YL (1,4'-BIPIPERIDINE)-1'-CARBOXYLATE
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Irinotecan Sucrosofate
Loading drug network...